I agree that this site is using cookies. You can find further informations here.
X
Liubao, Peng
182  results:
Search for persons X
?
1

Cost-Effectiveness of First-Line Versus Second-Line Pembrol..:

Chongqing, Tan ; Sini, Li ; Xiaohui, Zeng...
Frontiers in Pharmacology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
2

Cost–Utility Analysis of the Newly Recommended Adjuvant Che..:

Chongqing, Tan ; Liubao, Peng ; Xiaohui, Zeng...
PharmacoEconomics.  32 (2013)  3 - p. 235-243 , 2013
Link: https://doi.org/10.1007/..
 
?
3

Cost-Effectiveness Analysis of Adjuvant Therapy for Operabl..:

Liubao, Peng ; Xiaomin, Wan ; Chongqing, Tan...
PharmacoEconomics.  27 (2009)  10 - p. 873-886 , 2009
Link: https://doi.org/10.2165/..
 
?
4

Clinical efficacy and safety of 16 Chinese patent medicines..:

Peng, Ciyan ; Chen, Jing ; Li, Sini...
Pharmacological Research - Modern Chinese Medicine.  11 (2024)  - p. 100449 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and safety of Chinese patent medicines combined wi..:

Yi, Lidan ; Chen, Jing ; Li, Sini...
Journal of Psychiatric Research.  176 (2024)  - p. 205-212 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low A..:

Peng, Ye ; Wang, Liting ; Peng, Liubao...
Clinical Therapeutics.  45 (2023)  10 - p. 965-972 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Comparative efficacy and safety of various Chinese patent m..:

Peng, Ciyan ; Chen, Jing ; Li, Sini...
Pharmacological Research - Modern Chinese Medicine.  8 (2023)  - p. 100296 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Clinical Benefit and Cost Effectiveness of Risk-Stratified ..:

Qin, Shuxia ; Wang, Xuehong ; Li, Sini...
PharmacoEconomics.  40 (2022)  7 - p. 725-737 , 2022
Link: https://doi.org/10.1007/..
 
?
9

Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combin..:

Luo, Xia ; Liu, Qiao ; Zhou, Zhen...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

Comparative efficacy of various CHIs combined with western ..:

Peng, Ciyan ; Chen, Jing ; Cui, Wei...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
11

Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versu..:

Liu, Qiao ; Zhou, Zhen ; Luo, Xia...
Frontiers in Pharmacology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as ..:

Peng, Ye ; Zeng, Xiaohui ; Peng, Liubao...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
13

Cost-effectiveness of ensartinib, crizotinib, ceritinib, al..:

Luo, Xia ; Zhou, Zhen ; Zeng, Xiaohui..
Frontiers in Public Health.  10 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
14

Cost-Effectiveness Analysis of Adding Daratumumab to a Regi..:

Zeng, Xiaohui ; Liu, Qiao ; Peng, Liubao...
Advances in Therapy.  38 (2021)  5 - p. 2379-2390 , 2021
Link: https://doi.org/10.1007/..
 
?
15

First-Line ICI Monotherapies for Advanced Non-small-cell Lu..:

Liu, Qiao ; Zhou, Zhen ; Luo, Xia...
Frontiers in Pharmacology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
1-15